DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Zelenetz AD, Ahmed I, Braud EL et al.
NCCN biosimilars white paper: regulatory, scientific, and patient safety perspectives.
J Natl Compr Canc Netw 2011;
9: S1-S22
We do not assume any responsibility for the contents of the web pages of other providers.